FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

28022911000001102: Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
88698901000001110 Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106048601000001110 Vokanamet 50mg/850mg tablets (Napp Pharmaceuticals Ltd) 60 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Is a Canagliflozin 50mg / Metformin 850mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has AMP Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient Canagliflozin hemihydrate false Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient Canagliflozin hemihydrate true Inferred relationship Existential restriction modifier
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Has basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start